Bellerophon Therapeutics, Inc. Skyrocketed

Mon 10 Feb 20 at 05:41 PM
Bellerophon Therapeutics, Inc. Skyrocketed

Bellerophon Therapeutics, Inc. (BLPH:NASDAQ) rocketted at $4, representing a gain of 1335.2%. On Fri 07 Feb 20, BLPH:NASDAQ hit a New 2-Week Low of $0.28. The stock got featured on our News Catalysts scanner on Fri 07 Feb 20 at 12:59 PM in the 'SPLIT' category. From Fri 17 Jan 20, the stock recorded 7.14% Up Days and 6.67% Green Days

About Bellerophon Therapeutics, Inc. (BLPH:NASDAQ)

Bellerophon Therapeutics Inc is a clinical-stage biotherapeutics company. It develops products that are focused on the treatment of various types of pulmonary hypertension disorder.

Share